What is she best known for?
The fields of study she is best known for:
Her primary areas of study are Biochemistry, Carcinogen, Enzyme, DNA and Cytochrome P450.
The Biochemistry study combines topics in areas such as Molecular biology and Kidney.
Her Carcinogen research incorporates elements of NADPH:quinone reductase, Xanthine oxidase, Cofactor, Deoxyadenosine and NAD+ kinase.
Her study in the fields of Pyruvate carboxylase under the domain of Enzyme overlaps with other disciplines such as Aromatase.
Her study in DNA is interdisciplinary in nature, drawing from both Adduct, Stereochemistry and Mechanism of action.
Her Cytochrome P450 research integrates issues from Peroxidase, Oxidative phosphorylation, Pharmacology and Flavonoid.
Her most cited work include:
- Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450 (496 citations)
- Histone Deacetylase Inhibitors as Anticancer Drugs. (418 citations)
- The role of metallothionein in oxidative stress. (405 citations)
What are the main themes of her work throughout her whole career to date?
Marie Stiborová focuses on Biochemistry, Enzyme, Carcinogen, Cytochrome P450 and Microsome.
Metabolite, DNA, Reductase, Peroxidase and Metabolism are subfields of Biochemistry in which her conducts study.
The concepts of her Enzyme study are interwoven with issues in Kidney and Stereochemistry.
Her study looks at the relationship between Carcinogen and topics such as In vivo, which overlap with In vitro.
Her research in Cytochrome P450 intersects with topics in DNA adduct, Pharmacology and Benzopyrene.
Her Microsome research includes elements of Molecular biology and Cytochrome.
She most often published in these fields:
- Biochemistry (54.52%)
- Enzyme (32.35%)
- Carcinogen (28.51%)
What were the highlights of her more recent work (between 2014-2020)?
- Biochemistry (54.52%)
- Cytochrome P450 (27.38%)
- Enzyme (32.35%)
In recent papers she was focusing on the following fields of study:
The scientist’s investigation covers issues in Biochemistry, Cytochrome P450, Enzyme, Carcinogen and Cancer research.
Her Biochemistry study frequently links to adjacent areas such as Stereochemistry.
She interconnects Peroxidase, DNA adduct, Reductase and Benzopyrene in the investigation of issues within Cytochrome P450.
Her Enzyme research is multidisciplinary, incorporating perspectives in DNA and In vivo.
Her Carcinogen research focuses on Pharmacology and how it connects with Aristolochic acid I, Cardiotoxicity, Small intestine and Metallothionein.
Marie Stiborová has included themes like Prostate, Apoptosis, Histone deacetylase, Neuroblastoma and Epigenetics in her Cancer research study.
Between 2014 and 2020, her most popular works were:
- Histone Deacetylase Inhibitors as Anticancer Drugs. (418 citations)
- Balkan endemic nephropathy: an update on its aetiology (53 citations)
- Pulmonary Inflammation Impacts on CYP1A1-Mediated Respiratory Tract DNA Damage Induced by the Carcinogenic Air Pollutant Benzo[a]pyrene (46 citations)
In her most recent research, the most cited papers focused on:
Her main research concerns Biochemistry, Pharmacology, Cytochrome P450, Carcinogen and Molecular biology.
Many of her studies on Biochemistry involve topics that are commonly interrelated, such as Alkaloid.
Her Pharmacology research is multidisciplinary, incorporating perspectives in Cisplatin, Cancer cell, Etoposide, Histone deacetylase and Metallothionein.
Her biological study spans a wide range of topics, including Reductase, Biotransformation, Drug metabolism and Benzopyrene.
The various areas that Marie Stiborová examines in her Carcinogen study include Xenobiotic, Gastrointestinal tract, Metabolite, Glucuronosyltransferase and Genotoxicity.
Her Molecular biology study incorporates themes from Microsome and Prostate cancer, LNCaP.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
